StockClub

INM

INMInMed Pharmaceuticals Inc.$ --
InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc.

INM

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2026 Q2
Revenue
1M USD
YoY +1.2%
Operating Income
-3M USD
YoY -31.9%
Net Income
-3M USD
YoY -8.1%
EPS
-703.84$
YoY -19236.3%

Revenue

$2.2M
FY2024 Q3$3.3M
$3.3M
Q3
FY2024 Q4$4.6M
$4.6M
Q4
FY2025 Q1$1.3M
$1.3M
Q1
FY2025 Q2$2.4M
$2.4M
Q2
FY2025 Q3$3.6M
$3.6M
Q3
FY2025 Q4$5.4M
$5.4M
Q4
FY2026 Q1$1.1M
$1.1M
Q1
FY2026 Q2$2.2M
$2.2M
Q2
Actual
$-130,820 (-5.5%)

Net Income

$-4.5M
FY2024 Q3$-5.7M
$-5.7M
Q3
FY2024 Q4$-7.7M
$-7.7M
Q4
FY2025 Q1$-1.7M
$-1.7M
Q1
FY2025 Q2$-4.3M
$-4.3M
Q2
FY2025 Q3$-6.4M
$-6.4M
Q3
FY2025 Q4$-8.8M
$-8.8M
Q4
FY2026 Q1$-1.7M
$-1.7M
Q1
FY2026 Q2$-4.5M
$-4.5M
Q2
Actual
$-256,992 (-6.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:CAD0
FY2020
CAD0
FY2021
Actual:CAD0
FY2021
CAD0
FY2022MISS
Actual:CAD1.1M
Est:CAD1.8M
FY2022MISS
CAD1.1M
FY2023BEAT
Actual:CAD4.1M
Est:CAD4.1M
FY2023BEAT
CAD4.1M
FY2024MISS
Actual:CAD4.6M
Est:CAD5.4M
FY2024MISS
CAD4.6M
FY2025MISS
Actual:CAD4.9M
Est:CAD6.8M
FY2025MISS
CAD4.9M

Analyst Estimates

No forecast data